Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 1401 | Xp11.3 | KDM6A | lysine demethylase 6A | |
Mouse | - | 1401 | X 13.45 cM | Kdm6a | lysine (K)-specific demethylase 6A | |
Rat | - | - | X | Uty | ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
Database Links | |
Alphafold | O15550 (Hs), O70546 (Mm) |
CATH/Gene3D | 1.25.40.10 |
ChEMBL Target | CHEMBL2069164 (Hs) |
Ensembl Gene | ENSG00000147050 (Hs), ENSMUSG00000037369 (Mm), ENSRNOG00000060617 (Rn) |
Entrez Gene | 7403 (Hs), 22289 (Mm), 100310845 (Rn) |
Human Protein Atlas | ENSG00000147050 (Hs) |
KEGG Gene | hsa:7403 (Hs), mmu:22289 (Mm), rno:100310845 (Rn) |
OMIM | 300128 (Hs) |
Pharos | O15550 (Hs) |
RefSeq Nucleotide | NM_021140 (Hs), NM_009483 (Mm) |
RefSeq Protein | NP_066963 (Hs), NP_033509 (Mm) |
UniProtKB | O15550 (Hs), O70546 (Mm) |
Wikipedia | KDM6A (Hs) |
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immunopharmacology Comments |
KDM6A and KDM6B have been reported as key regulators of metabolic switches that are involved in metabolic reprogramming of human T helper cell subsets [1]. In vitro, inhibition by GSK-J4 (the ester prodrug of GSK-J1, a KDM6A/B inhibitor) increases repressive H3K27me3 histone marks which causes down-regulation of the key transcription factor RORγt during Th17 differentiation, and in mature Th17 cells leads to metabolic reprogramming, suppression of IL-17 cytokine levels and reduced proliferation. This work suggests that inhibiting KDM6 demethylases may be an effective intervention in autoimmune inflammation. |
1. Cribbs AP, Terlecki-Zaniewicz S, Philpott M, Baardman J, Ahern D, Lindow M, Obad S, Oerum H, Sampey B, Mander PK et al.. (2020) Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Proc Natl Acad Sci USA, 117 (11): 6056-6066. [PMID:32123118]
2. Heinemann B, Nielsen JM, Hudlebusch HR, Lees MJ, Larsen DV, Boesen T, Labelle M, Gerlach LO, Birk P, Helin K. (2014) Inhibition of demethylases by GSK-J1/J4. Nature, 514 (7520): E1-2. [PMID:25279926]
3. Horton JR, Woodcock CB, Chen Q, Liu X, Zhang X, Shanks J, Rai G, Mott BT, Jansen DJ, Kales SC et al.. (2018) Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A. J Med Chem, 61 (23): 10588-10601. [PMID:30392349]
1.14.11.- Histone demethylases: lysine demethylase 6A. Last modified on 04/03/2020. Accessed on 21/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2684.